Agiliti Inc (NYSE:AGTI)
$ 10.05 0 (0%) Market Cap: 1.37 Bil Enterprise Value: 2.52 Bil PE Ratio: 0 PB Ratio: 1.45 GF Score: 60/100

Agiliti Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 12, 2023 / 04:15PM GMT
Release Date Price: $7.87 (+0.38%)
Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

Thank you, everyone, for joining us this afternoon, and I'm Andrew Ranieri, one of the medical device analyst here. And it's my pleasure to have the Agiliti management team with us today, CEO, Tom Boehning and CFO, Jim Pekarek.

Before we get started, just a quick disclosure, please see the Morgan Stanley research disclosure websites for important disclosures disclaimers. If you have any questions, please reach out to your sales rep.

But with that, let's kind of get into the discussion.

Questions & Answers

Andrew Christopher Ranieri
Morgan Stanley, Research Division - Equity Analyst

I first thought it might be helpful, Tom, if you might kind of give us kind of a 10,000-foot level view of the company today, and maybe some quick background on the company, and market you compete. And then we can kind of dig into some of the other questions.

Thomas W. Boehning
Agiliti, Inc. - CEO, President & Director

Well,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot